We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05243550
Brief Title: A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (ENVISION)

First Submitted : February 7, 2022
First Submitted that Met QC Criteria : February 7, 2022
First Posted : February 17, 2022

Last Update Submitted that Met QC Criteria : December 16, 2022
Last Update Posted : December 20, 2022